TP53 and cancer: Firstly, whether males are more inherently exposed to damaging carcinogenic stimuli than females; and secondly, whether males are less able to mount remedial responses to both external and internal genomic damage than females (a concept introduced in “Altered TP53 Regulation and Its Cancer Risks for Females and Males” section)?